Summary Each year, the American Heart Association (AHA), in conjunction with the Centers
for Disease Control and Prevention, the National Institutes of Health, and other government …

Globally, cardiovascular disease (CVD) is the number one killer of women; one third of
female deaths are due to ischemic heart disease and stroke (WHO, 2013). Historically …

The management of acute myocardial infarction (AMI) 1 has evolved over the past century
and particularly in the past 50 years. Important milestones include the development of the …

Background Women with ST‐segment–elevation myocardial infarction (STEMI) have higher
mortality rates than men. We investigated whether sex‐related differences in timely access …

Background: Few data are available comparing cardiovascular disease (CVD) biomarker
profiles between women and men in the general population. We analyzed sex-based …

Background—The WISE study (Women's Ischemia Syndrome Evaluation) was a prospective
cohort study of 936 clinically stable symptomatic women who underwent coronary …

Cardiovascular disease (CVD) in women remains under-diagnosed and undertreated due to
the diagnostic challenge it presents, as well as the persisting attitude that CVD …

To determine gender differences and predictors of all-cause mortality (30 days and 1 year)
after percutaneous coronary intervention (PCI) in patients with stable angina pectoris and …

Background Women hospitalized with a non‐ST segment elevation acute coronary
syndrome (ACS) have worse clinical outcomes compared with men. An early invasive …

Background The objective was to investigate whether gender disparities are found in
referrals of patients with acute coronary syndromes to percutaneous coronary interventions …